Table 1.
Sample | Alteration | MF (%) |
Surgical specimen |
KRAS G12V | 21.12 |
TP53 Splice Site SNV | 95.7 | |
Spheroids |
KRAS G12V | 45.6 |
TP53 Splice Site SNV | 97.1 | |
Circulating tumour DNA |
KRAS G12V | 39.1 |
TP53 Splice Site SNV | 17.5 |
MF, molecular fraction; NGS, next generation sequencing; SNV, single nucleotide variant.